<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for https://www.marketbeat.com/feed/</title><link>https://www.marketbeat.com/feed/</link><description>Individual feed output.</description><lastBuildDate>Wed, 19 Nov 2025 22:12:58 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>onsemi Places a $6 Billion Bet on Its Own Stock</title><link>https://www.marketbeat.com/originals/onsemi-places-a-6-billion-bet-on-its-own-stock/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture1.png</image_url><description>onsemi's new multi-billion-dollar share repurchase program signals strong management confidence in its future growth and commitment to shareholder val...</description><pubDate>Wed, 19 Nov 2025 17:22:00 GMT</pubDate></item><item><title>HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?</title><link>https://www.marketbeat.com/originals/hims-has-been-a-roller-coaster-ride-should-investors-hop-on/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture10.png</image_url><description>Hims &amp; Hers Health may only generate a fraction of its competitors revenue, but its fiscal management and exponential growth point to a very bright fu...</description><pubDate>Wed, 19 Nov 2025 16:27:00 GMT</pubDate></item><item><title>End the Year Strong With These 3 Comeback Champions</title><link>https://www.marketbeat.com/stock-ideas/end-the-year-strong-with-these-3-comeback-champions/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture6.png</image_url><description>Delta Air Lines, Diamondback Energy, and HEICO could all benefit from internal and external drivers of momentum heading into the end of the year.</description><pubDate>Wed, 19 Nov 2025 15:08:00 GMT</pubDate></item><item><title>Down 45% Year-to-Date, Novo Nordisk Ignites a Price War</title><link>https://www.marketbeat.com/originals/down-45-year-to-date-novo-nordisk-ignites-a-price-war/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture4.png</image_url><description>Novo Nordisk's new pricing for its GLP-1 drugs is a strategic pivot to capture a mass market, pressure rivals, and secure long-term market dominance.</description><pubDate>Wed, 19 Nov 2025 12:04:00 GMT</pubDate></item><item><title>Institutions Love These 3 Companies, Should You As Well?</title><link>https://www.marketbeat.com/originals/institutions-love-these-3-companies-should-you-as-well/</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture8.png</image_url><description>Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional invest...</description><pubDate>Wed, 19 Nov 2025 11:45:00 GMT</pubDate></item></channel></rss>